Indore, IN: Bizwit Research & Consulting LLP’s Recent Analysis on Global Blood Screening Market is poised to raise up to USD 4.9 billion by 2027. Blood screening refers to numerous tests conducted on blood samples to detect multiple diseases such as AIDS, hepatitis, syphilis and other health conditions such as pregnancy. It involves monitoring diseases and prevent health problems and a variety of other diseases such as cancer and infections. Screening of blood donors is the defense mechanism implemented to prevent the spread of infection before donating blood.
Growing numbers of blood donations and blood donors with growing consciousness about preserving donated blood and growing occurrence of transferable illnesses, growing call for donated blood, rise in spending on fitness, technical developments in blood screening, growing alertness for fitness and increasing number of initiatives by many administrations and government associations are a few important issues motivating the development of the global blood screening market size.
The global Blood Screening market industry is highly competitive owing to the presence of several key manufacturers such as Grifols, F. Hoffmann-La Roche, Abbott Laboratories, Biomerieux, Bio-Rad Laboratories, Inc., Siemens Healthineers, Ortho Clinical Diagnostics, Inc., Thermo Fisher Scientific, Inc., Beckman Coulter and Becton, Dickinson & Company
For further analysis on this or to request a sample copy of this report, please click the link mentioned below:
Key findings of the study suggest:
- Global Blood Screening Market industry is anticipated to grow with a healthy growth rate of more than 9.7 % over the forecast period 2020-2027.
- North America accounted for the largest market share owing to increasing prevalence of newer pathogens, presence of high-quality hospital and clinical laboratory infrastructure in the region
- Growing healthcare sector along with growing technological development will further boost various opportunities in the blood screening market during the forecast period.
- The Blood Screening market can be chiefly attributed to the increasing prevalence of infectious diseases
Bizwit Research & Consulting LLP has considered following segments for the study:
- Nucleic Acid Test (NAT)
- Rapid Test
- Western Blot Assay
- Next-Generation Sequencing (NGS)
Product & Services:
- Reagents & Kits
- Software & Service
- Blood Bank
- North America
- Asia Pacific
- Latin America
- Rest of the World
To get a sample of this report or to purchase a copy of the study, you can directly contact us at: [email protected]
Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. The company has a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. Bizwit incorporate big data, expert analysis, and huge industry database to deliver client focused business consulting reports. Our analysts perform unbiased measurement and assessment of market opportunities to comprehend detailed market forecast. Our team of key opinion leaders evaluates the market size, growth prospects, end-use, applications, value & supply chain and top vendors in the industry to help the clients to take conversant business decisions without any vague assumptions.
Global Business Development
Phone: +91 999 3115879
Email: [email protected]